SYNAPTOGENIX INC (SNPX) Stock Income Statement
NASDAQ:SNPX - Nasdaq - US87167T3005 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 6.19M | 6.81M | 8.31M | 16.14M | 12.62M | |||
| Research and Development | 1.05M | 1.60M | 1.97M | 6.32M | 4.34M | |||
| Selling, General, and Administrative Expenses | 5.14M | 5.21M | 6.34M | 9.81M | 8.28M | |||
| Operating Income | -6.19M | -6.81M | -8.31M | -16.14M | -12.62M | |||
| Interest Income/Expense | 940.00K | 2.26M | 905.30K | 2.16M | 7.10K | |||
| Other Income/Expense | -3.97M | -5.26M | 1.37M | 8.40M | N/A | |||
| Non Recurring Items | N/A | -2.96M | N/A | N/A | 0.00 | |||
| Income Before Taxes | -12.18M | -12.77M | -6.04M | -5.57M | -12.61M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -12.97M | -13.56M | -13.78M | -5.69M | -12.61M | |||
| EBITDA | -6.18M | -6.81M | -8.31M | -16.13M | -12.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.81 | -10.99 | -29.56 | -20.35 | -62.87 | |||
| Non GAAP EPS | N/A | N/A | N/A | -51.75 | N/A | |||
| Statistics | ||||||||
All data in USD